Table 2.
Distribution of the genotypes and alleles of the rs6573604, rs11621121, rs10483776, and rs4073416 polymorphisms in the control participants and the patients with PTSD.
| SNP | Genotype/Allele | Control Participants | Patients with PTSD | Statistics | ||
|---|---|---|---|---|---|---|
| N | % | N | % | |||
| rs6573604 | CC | 20 | 8.1% | 11 | 3.7% | χ2 = 5.861; df = 2; p = 0.053 |
| CT | 69 | 28.1% | 75 | 25.4% | ||
| TT | 157 | 63.8% | 209 | 70.8% | ||
| C | 109 | 22.2% | 97 | 16.4% | χ2 = 5.682; df = 1; p = 0.017 | |
| T | 383 | 77.8% | 493 | 83.6% | ||
| rs11621121 | CC | 51 | 20.7% | 58 | 19.7% | χ2 = 2.571; df = 2; p = 0.277 |
| CT | 124 | 50.4% | 133 | 45.1% | ||
| TT | 71 | 28.9% | 104 | 35.3% | ||
| C | 226 | 45.9% | 249 | 42.2% | χ2 = 1.517; df = 1; p = 0.218 | |
| T | 266 | 54.1% | 341 | 57.8% | ||
| rs10483776 | AA | 160 | 65.0% | 179 | 60.7% | χ2 = 2.473; df = 2; p = 0.290 |
| AG | 75 | 30.5% | 107 | 36.3% | ||
| GG | 11 | 4.5% | 9 | 3.1% | ||
| A | 395 | 80.3% | 465 | 78.8% | χ2 = 0.356; df = 1; p = 0.551 | |
| G | 97 | 19.7% | 125 | 21.2% | ||
| rs4073416 | CC | 46 | 18.7% | 43 | 14.6% | χ2 = 2.958; df = 2; p = 0.228 |
| CT | 114 | 46.3% | 157 | 53.2% | ||
| TT | 86 | 35.0% | 95 | 32.2% | ||
| C | 206 | 41.9% | 243 | 41.2% | χ2 = 0.052; df = 1; p = 0.820 | |
| T | 286 | 58.1% | 347 | 58.8% | ||
Data are presented as total count (N) and frequency (%) and analyzed using the χ2-test. p-value denoted in bold is considered statistically significant. SNP—single nucleotide polymorphism.